Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

390 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?
Yaro S, Njanpop Lafourcade BM, Ouangraoua S, Ouoba A, Kpoda H, Findlow H, Tall H, Seanehia J, Martin C, Ouedraogo JB, Gessner B, Meda N, Borrow R, Trotter C, Mueller JE. Yaro S, et al. Among authors: meda n. Clin Infect Dis. 2019 Jan 18;68(3):435-443. doi: 10.1093/cid/ciy488. Clin Infect Dis. 2019. PMID: 30481265
Epidemiology of HIV infection in urban Burkina Faso.
Lagarde E, Congo Z, Meda N, Baya B, Yaro S, Sangli G, Traoré Y, Van Renthergem H, Caraël M; Study Group on HIV Dynamic Among Young Adults in Burkina Faso. Lagarde E, et al. Among authors: meda n. Int J STD AIDS. 2004 Jun;15(6):395-402. doi: 10.1258/095646204774195254. Int J STD AIDS. 2004. PMID: 15186585
Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels.
Nagot N, Ouedraogo A, Konate I, Weiss HA, Foulongne V, Defer MC, Sanon A, Becquart P, Segondy M, Sawadogo A, Van de Perre P, Mayaud P; ANRS 1285 Study Group. Nagot N, et al. J Infect Dis. 2008 Jul 15;198(2):241-9. doi: 10.1086/589621. J Infect Dis. 2008. PMID: 18593294 Clinical Trial.
Bacterial vaginosis among pregnant women in Burkina Faso.
Kirakoya-Samadoulougou F, Nagot N, Defer MC, Yaro S, Meda N, Robert A. Kirakoya-Samadoulougou F, et al. Among authors: meda n. Sex Transm Dis. 2008 Dec;35(12):985-9. doi: 10.1097/OLQ.0b013e3181844f22. Sex Transm Dis. 2008. PMID: 18779763
Low prevalence rate of indeterminate serological human immunodeficiency virus results among pregnant women from Burkina Faso, West Africa.
Kania D, Fao P, Valéa D, Gouem C, Kagoné T, Hien H, Somda P, Ouédraogo P, Drabo A, Gampini S, Méda N, Diagbouga S, Van de Perre P, Rouet F; WHO/ANRS 1289 Kesho Bora Study Group in Burkina Faso. Kania D, et al. Among authors: meda n. J Clin Microbiol. 2010 Apr;48(4):1333-6. doi: 10.1128/JCM.01734-09. Epub 2010 Feb 3. J Clin Microbiol. 2010. PMID: 20129958 Free PMC article.
Low seroprevalence of syphilis in Burkina Faso.
Kirakoya-Samadoulougou F, Defer MC, Yaro S, Fao P, Ilboudo F, Langani Y, Meda N, Robert A, Nagot N. Kirakoya-Samadoulougou F, et al. Among authors: meda n. Sex Transm Infect. 2011 Feb;87(1):35-7. doi: 10.1136/sti.2010.042465. Epub 2010 Aug 5. Sex Transm Infect. 2011. PMID: 20693149
390 results